CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 134 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,864,000 | +94.3% | 271,430 | 0.0% | 0.16% | +51.4% |
| Q2 2022 | $1,474,000 | -40.9% | 271,430 | 0.0% | 0.11% | -0.9% |
| Q1 2022 | $2,492,000 | -39.2% | 271,430 | 0.0% | 0.11% | -27.5% |
| Q4 2021 | $4,096,000 | -36.8% | 271,430 | 0.0% | 0.15% | -29.0% |
| Q3 2021 | $6,479,000 | – | 271,430 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 544,196 | $5,741,000 | 19.52% |
| Elmwood Wealth Management, Inc. | 2,364,240 | $24,943,000 | 12.45% |
| 72 Investment Holdings, LLC | 474,067 | $5,001,000 | 3.96% |
| PFM Health Sciences, LP | 6,000,000 | $63,300,000 | 2.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 257,892 | $2,716,000 | 0.87% |
| Avidity Partners Management LP | 3,172,600 | $33,471,000 | 0.68% |
| Rokos Capital Management LLP | 1,907,509 | $20,811,000 | 0.62% |
| Green Alpha Advisors, LLC | 69,376 | $732,000 | 0.62% |
| Nelson Capital Management, LLC | 85,020 | $897,000 | 0.26% |
| Tekla Capital Management LLC | 567,147 | $5,983,000 | 0.24% |